Anderson Schock
Stock Analyst at B. Riley Securities
(4.12)
# 1,781
Out of 4,668 analysts
42
Total ratings
62.2%
Success rate
19.7%
Average return
Main Sectors:
Stocks Rated by Anderson Schock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VREX Varex Imaging | Downgraded: Hold | $18 → $19 | $18.49 | +2.22% | 5 | Aug 10, 2026 | |
| LFMD LifeMD | Maintained: Buy | $10 → $8 | $3.28 | +143.90% | 2 | Aug 6, 2026 | |
| INFU InfuSystem Holdings | Rated: Buy | $12 → $20 | $12.20 | +63.93% | 3 | Aug 5, 2026 | |
| XGN Exagen | Rated: Buy | $8 → $12 | $7.78 | +54.24% | 5 | Aug 5, 2026 | |
| ANIK Anika Therapeutics | Maintained: Buy | $18 → $21 | $21.34 | -1.59% | 4 | Jul 30, 2026 | |
| NUTX Nutex Health | Initiated Coverage: Buy | $290 | $188.54 | +53.81% | 1 | Jun 26, 2026 | |
| CLPT ClearPoint Neuro | Maintained: Buy | $20 → $30 | $15.19 | +97.50% | 5 | Jun 17, 2026 | |
| OBIO Orchestra BioMed Holdings | Reiterated: Buy | $10 | $5.43 | +84.16% | 1 | May 18, 2026 | |
| ELMD Electromed | Maintained: Buy | $38 → $40 | $40.00 | - | 2 | May 13, 2026 | |
| OPRX OptimizeRx | Reiterated: Buy | $11 → $10 | $7.96 | +25.63% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $32 → $36 | $23.43 | +53.65% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.4783 | +736.30% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 | $10.44 | +34.10% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.49 | +235.57% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $5.60 | +150.00% | 3 | Jan 21, 2026 |
Varex Imaging
Aug 10, 2026
Downgraded: Hold
Price Target: $18 → $19
Current: $18.49
Upside: +2.22%
LifeMD
Aug 6, 2026
Maintained: Buy
Price Target: $10 → $8
Current: $3.28
Upside: +143.90%
InfuSystem Holdings
Aug 5, 2026
Rated: Buy
Price Target: $12 → $20
Current: $12.20
Upside: +63.93%
Exagen
Aug 5, 2026
Rated: Buy
Price Target: $8 → $12
Current: $7.78
Upside: +54.24%
Anika Therapeutics
Jul 30, 2026
Maintained: Buy
Price Target: $18 → $21
Current: $21.34
Upside: -1.59%
Nutex Health
Jun 26, 2026
Initiated Coverage: Buy
Price Target: $290
Current: $188.54
Upside: +53.81%
ClearPoint Neuro
Jun 17, 2026
Maintained: Buy
Price Target: $20 → $30
Current: $15.19
Upside: +97.50%
Orchestra BioMed Holdings
May 18, 2026
Reiterated: Buy
Price Target: $10
Current: $5.43
Upside: +84.16%
Electromed
May 13, 2026
Maintained: Buy
Price Target: $38 → $40
Current: $40.00
Upside: -
OptimizeRx
May 13, 2026
Reiterated: Buy
Price Target: $11 → $10
Current: $7.96
Upside: +25.63%
May 7, 2026
Upgraded: Buy
Price Target: $32 → $36
Current: $23.43
Upside: +53.65%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $0.4783
Upside: +736.30%
Feb 26, 2026
Downgraded: Hold
Price Target: $14
Current: $10.44
Upside: +34.10%
Feb 10, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.49
Upside: +235.57%
Jan 21, 2026
Reiterated: Buy
Price Target: $14
Current: $5.60
Upside: +150.00%